1
|
Wang Y, Zhang Q, Wei Y, Cai X, Li Z, Wu Q, Zhang X, Deng C, Shu P, Xiang Q. Retinol semisolid preparations in cosmetics: transcutaneous permeation mechanism and behaviour. Sci Rep 2024; 14:22793. [PMID: 39354022 PMCID: PMC11445495 DOI: 10.1038/s41598-024-73240-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Accepted: 09/16/2024] [Indexed: 10/03/2024] Open
Abstract
Retinol is widely used to treat skin ageing because of its effect on cell differentiation, proliferation and apoptosis. However, its potential benefits appear to be limited by its skin permeability. Herein, we investigated the transcutaneous behavior of retinol in semisolid cosmetics, in both in vitro and in vivo experiments. In vitro experiments used the modified Franz diffusion cell combined with Raman spectroscopy. In in vivo experiments, the content of retinol in rat skin and plasma was detected with HPLC. Retinol in semisolid cosmetics was mainly concentrated in the stratum corneum in the skin of the three animal models tested, and in any case did not cross the skin barrier after a 24 h dermatologic topical treatment in Franz diffusion cells tests. Similar results were obtained in live mice and rats, where retinol did not cross the skin barrier and did not enter the blood circulation. Raman spectroscopy was used to test the penetration depth of retinol in skin, which reached 16 μm out of 34 μm in pig skin, whereas the skin of mouse and rat showed too strong bakground interference. To explore epidermal transport mechanism and intradermal residence, skin transcriptomics was performed in rats, which identified 126 genes upregulated related to retinol transport and metabolism, relevant to the search terms "retinoid metabolic process" and "transporter activity". The identity of these upregulated genes suggests that the mechanism of retinol action is linked to epidermis, skin, tissue and epithelium development.
Collapse
Affiliation(s)
- Yuan Wang
- HBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd, Shenzhen, 518000, Guangdong, People's Republic of China
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China
| | - Qirong Zhang
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China
- Biopharmaceutical R&D Center of Jinan University, Guangzhou, 510000, China
- Guangzhou Jike Meichuang Co., Ltd, Guangzhou, 510000, China
| | - Yongsheng Wei
- Biopharmaceutical R&D Center of Jinan University, Guangzhou, 510000, China
| | - Xiang Cai
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China
- Biopharmaceutical R&D Center of Jinan University, Guangzhou, 510000, China
| | - Zhiwei Li
- HBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd, Shenzhen, 518000, Guangdong, People's Republic of China
| | - Qingyun Wu
- HBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd, Shenzhen, 518000, Guangdong, People's Republic of China
| | - Xinyi Zhang
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China
- Biopharmaceutical R&D Center of Jinan University, Guangzhou, 510000, China
| | - Chaoqing Deng
- Guangzhou Jike Meichuang Co., Ltd, Guangzhou, 510000, China
| | - Peng Shu
- HBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd, Shenzhen, 518000, Guangdong, People's Republic of China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China.
| | - Qi Xiang
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, China.
- Biopharmaceutical R&D Center of Jinan University, Guangzhou, 510000, China.
- Guangzhou Jike Meichuang Co., Ltd, Guangzhou, 510000, China.
| |
Collapse
|
2
|
Lincha VR, Hsiao CH, Zhao J, Li C, Chow DSL. Sensitive and rapid UHPLC-MS/MS assay for simultaneous quantifications of calcipotriol and paclitaxel in rat whole blood and plasma samples. J Pharm Biomed Anal 2020; 192:113685. [PMID: 33099115 DOI: 10.1016/j.jpba.2020.113685] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2020] [Revised: 10/04/2020] [Accepted: 10/09/2020] [Indexed: 10/23/2022]
Abstract
Vitamin-D analogues have emerged as potential stroma-modulating agents for the treatment of pancreatic ductal adenocarcinoma (PDAC). One such agent, calcipotriol (Cal) has shown significant activity in in vitro and in vivo models of pancreatic ductal adenocarcinoma. Attempts in our lab have been focused on establishing the therapeutic merits of co-formulating this agent with the chemotherapeutic drug paclitaxel (PTX) in animal models. Accurate and reliable quantifications of these agents is critical to successful pharmacokinetic/pharmacodynamic (PK/PD) projections from animals into humans. Herein, we developed a LC-MS/MS assay for measuring Cal and PTX in whole blood and plasma. A liquid-liquid analyte extraction procedure, using a mixture of water-MeOH (50:50, v/v) and hexane-dichloromethane- isopropyl alcohol (150:15:5, v/v/v) was used. Chromatographic separation was carried out on Kinetex C18 column (1.7 μm, 100 × 2.10 mm) under an isocratic elution at a flow rate of 0.4 mL/min with a total runtime of 3.5 min. The mobile phase was composed of ammonium acetate (pH 6.51; 5 mM)-methanol (15:85, v/v). The analytes were ionized by positive electrospray ionization using API 5500-Qtrap triple quadrupole mass spectrometer (Applied Biosystem/AB SCIEX). The linearity of calibration curves for both analytes were established at 0.5 (LLOQ)-500 ng/mL with correlation coefficients exceeding 0.99. Spiked whole blood and plasma samples were used as surrogates for matrix validation. For both analytes, the intra-day and inter-day accuracies were 90.5-105 % and 96.6-106 %, respectively, while the corresponding precisions were 3.09-10.7 % and 5.20-12.9 %. No carryover was observed for the analytes which also remained acceptably stable in the surrogate matrices under relevant conditions. The assay is robust, reliable and sensitive in rat whole blood and plasma. The analytes extraction procedure performs acceptably well in both matrices with high recoveries and minimal matrix effects. Additionally, only 20 μL of rat whole blood or plasma is required and the total run time per sample is 3.5 min. PK studies enabled by the assay revealed that when co-administered, PTX AUC0→∞ and Cmax increased while those of Cal decreased. This finding alerts a potential drug-drug interaction and warrants further investigation in studies using this combination regimen.
Collapse
Affiliation(s)
- Victor R Lincha
- Department of Pharmaceutical and Pharmacological Sciences, College of Pharmacy, University of Houston, TX, USA.
| | - Cheng-Hui Hsiao
- Department of Pharmaceutical and Pharmacological Sciences, College of Pharmacy, University of Houston, TX, USA
| | - Jun Zhao
- Cancer Systems Imaging, The University of Texas M.D Anderson Cancer Center, Houston, TX 77054, USA; Huazhong University of Science and Technology, Wuhan, China
| | - Chun Li
- Cancer Systems Imaging, The University of Texas M.D Anderson Cancer Center, Houston, TX 77054, USA
| | - Diana S-L Chow
- Department of Pharmaceutical and Pharmacological Sciences, College of Pharmacy, University of Houston, TX, USA
| |
Collapse
|
3
|
Hosomi A, Hirabe M, Tokuda T, Nakamura H, Amano T, Okamoto T. Calcium effects and systemic exposure of vitamin D 3 analogues after topical treatment of active vitamin D 3 -containing ointments in rats. Eur J Pharmacol 2016; 788:98-103. [DOI: 10.1016/j.ejphar.2016.06.028] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2016] [Revised: 06/15/2016] [Accepted: 06/15/2016] [Indexed: 10/21/2022]
|